Try our Advanced Search for more refined results
February 25, 2014
In Re: BRCA1- and BRCA2- Based Hereditary Cancer Test Patent Litigation
Case Number:
2:14-md-02510
Court:
Nature of Suit:
Multi Party Litigation:
Multi-district Litigation
Judge:
Firms
- Dentons
- Fish & Richardson
- Foley & Lardner
- Groombridge Wu
- Hatch Law Group
- Jones Waldo
- Kilpatrick Townsend
- Kirkland & Ellis
- Magleby Cataxinos
- McDermott Will & Emery
- Morrison Foerster
- Parr Brown
- Parsons Behle
- Paul Weiss
- Pillsbury Winthrop
- Ray Quinney
- Robins Kaplan
- Sterne Kessler
- Thorpe North
- TraskBritt
Companies
- AARP Inc.
- Ambry Genetics Corp.
- American Civil Liberties Union
- Counsyl Inc.
- Invitae Corp.
- Myriad Genetics Inc.
- Pathway Genomics Corp.
- Quest Diagnostics Inc.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
February 06, 2015
Myriad Settles With Quest In Cancer Gene Test Patent MDL
Myriad Genetics Inc. on Friday settled patent infringement litigation with Quest Diagnostics Inc., dismissing claims in Utah federal court alleging Quest infringed Myriad's patents for BRCA cancer gene testing, some of which had been recently invalidated by the Federal Circuit.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login